ELECTROLYTE ADDITIVE, ELECTROLYTE INCLUDING THE SAME AND LITHIUMSECONDARY BATTERY INCLUDING THE ELECTROLYTE.

Provided are an electrolyte additive represented by the following formula (1), an electrolyte solution containing the electrolyte additive, and a lithium secondary battery including the electrolyte solution: 2. The electrolyte additive according to claim 1 , wherein the electrolyte additive is any one selected from the group consisting of methyl succinate claim 1 , ethyl succinate claim 1 , propyl succinate claim 1 , butyl succinate claim 1 , dimethyl succinate claim 1 , diethyl succinate claim 1 , dipropyl succinate claim 1 , dibutyl succinate claim 1 , and combinations thereof.4. The electrolyte solution for lithium secondary batteries according to claim 3 , wherein the electrolyte additive is any one selected from the group consisting of methyl succinate claim 3 , ethyl succinate claim 3 , propyl succinate claim 3 , butyl succinate claim 3 , dimethyl succinate claim 3 , diethyl succinate claim 3 , dipropyl succinate claim 3 , dibutyl succinate claim 3 , and combinations thereof.5. The electrolyte solution for lithium secondary batteries according to claim 3 , wherein the electrolyte additive is incorporated in an amount of 0.1% to 30% by weight relative to the total amount of the electrolyte solution.6. The electrolyte solution for lithium secondary batteries according to claim 3 , wherein the organic solvent is any one selected from the group consisting of ethylene carbonate (EC) claim 3 , propylene carbonate (PC) claim 3 , ethyl methyl carbonate (EMC) claim 3 , dimethyl carbonate (DMC) claim 3 , diethyl carbonate (DEC) claim 3 , fluoroethylene carbonate (FEC) claim 3 , methyl propyl carbonate (MPC) claim 3 , ethyl propyl carbonate (EPC) claim 3 , methyl ethyl carbonate (MEC) claim 3 , butylene carbonate (BC) and combinations thereof.7. The electrolyte solution for lithium secondary batteries according to claim 3 , wherein the organic solvent contains 10% to 30% by weight of ethylene carbonate (EC) claim 3 , 0% to 30% by weight of fluoroethylene carbonate (FEC) ...

PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY

The present invention relates to a composition comprising an extract of genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease. 1Pseudolysimachion. A method of treating inflammatory and allergic disease , comprising administering an extract of genus plant as an active ingredient to a subject in need thereof.2PseudolysimachionP. longifolium, P. ovatum, P. kiusianum, P. kiusianum var. diamanticum, P. kiusianum var. villosum, P. dahuricum, P. pyrethrinum, P. linarifolium, P. linarifolium var. villosulum, P. rotundum var. subintegrum, P. rotundum var. coreanumP. insulare.. The method of claim 1 , wherein the genus plant is selected from the group consisting of claim 1 , and3Pseudolysimachion. The method of claim 1 , wherein the extract is prepared by extracting the genus plant with a solvent selected from the group consisting of water claim 1 , lower alcohols claim 1 , acetone claim 1 , ethyl acetate claim 1 , chloroform claim 1 , dichloromethane and the mixtures thereof. This application is a divisional of U.S. patent application Ser. No. 11/916,216, filed Nov. 30, 2007, which is a 371 of PCT/KR2006/002092, filed May 30, 2006, which claims the benefit of Korean Patent Application Nos. 10-2005-0045756, filed May 30, 2005, 10-2005-0045755, filed May 30, 2005, 10-2006-0048319, filed May 29, 2006, and 10-2006-0048104, filed May 29, 2006, the contents of each of which are incorporated herein by reference its entirety.The present invention relates to a composition comprising an extract of ...

ASTHMA DIAGNOSIS USING THE NEUROPILIN-1 GENE, AND METHOD FOR SCREENING FOR A THERAPEUTIC AGENT FOR ASTHMA

The present invention relates to a kit for the diagnosis or screening of asthma comprising neuropilin (NRP) gene, and to a method for screening a therapeutic agent for asthma using the same. More precisely, the present invention confirmed that NRP1 expression was increased in asthma patients and by extract. Based on the confirmation, the inventors confirmed that NRP1 could be effectively used as a target for the development of a therapeutic agent for asthma since the suppression of NRP1 expression resulted in the decrease of mRNA, protein, enzyme activity, and promoter activity of MMP-9 in relation to asthma. 112-. (canceled)13. A method for the treatment of asthma comprising the step of administering a pharmaceutically effective dose of NRP1 (Neuropilin-1) gene expression or activity inhibitor to a subject with asthma.14. The method for the treatment of asthma according to claim 13 , wherein NRP1 expression or activity inhibitor is selected from the group consisting of antisense nucleotide binding complementarily to NRP1 mRNA claim 13 , short interfering RNA claim 13 , short hairpin RNA claim 13 , and antibody binding complementarily to NRP1 protein.1516-. (canceled)17. The method for the treatment of asthma according to claim 13 , wherein the NRP1 gene has the nucleotide sequence of SEQ. ID. NO: 1.18. A method for the treatment of asthma comprising the step of administering a pharmaceutically effective dose of NRP1 (Neuropilin-1) short interfering RNA to a subject with asthma.19. A method for the treatment of asthma comprising the step of administering a pharmaceutically effective dose of NRP1 (Neuropilin-1) antibody to a subject with asthma. 1. Field of the InventionThe present invention relates to a use of NRP1 gene as a target for the development of an asthma marker or a therapeutic agent for asthma.2. Description of the Related ArtAnaphylaxis, allergic rhinitis, asthma, atopic dermatitis, and urticaria are the examples of allergic diseases whose incidence ...

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, ALLERGIC DISEASES OR ASTHMA, CONTAINING DIOSPYROS BLANCOI A. DC. EXTRACT AS ACTIVE INGREDIENT

Disclosed is a pharmaceutical composition for the prophylaxis and therapy of inflammatory diseases, allergic diseases, or asthma, comprising a velvet apple (A. DC.) extract as an active ingredient. Having the inhibitory activity against the nuclear translocation of NF-κB, whose level is rapidly elevated in response to inflammatory stimuli, the velvet apple extract can suppress the production of NO and PGE, the expression of iNOS and COX-2, and the release of IL-1β and TNF-α, and can significantly down regulate Th2-mediated IL-4 and IL-13 production. In addition, the extract was found to inhibit the activation of eosinophils in bronchoalveolar lavage fluid, and to suppress the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood, as measured by in vivo tests on an ovalbumin-induced asthma mouse model. Therefore, the extract can be used in the method for preventing or treating various inflammatory disorders, allergic diseases, or asthma. 115-. (canceled)16Diospyros blancoi. A method for treating inflammatory disease comprising administering an amount of a velvet apple (A. DC.) extract to a subject in need thereof effect to treat said inflammatory disease.17Diospyros blancoi. The method according to claim 16 , wherein the velvet apple (A. DC.) extract is characteristically extracted by using water claim 16 , C˜Clower alcohol claim 16 , or the mixture of the same as a solvent.18. The method according to claim 17 , wherein the lower alcohol is ethanol or methanol.19. The method according to claim 16 , wherein the inflammatory disease is selected from the group consisting of dermatitis claim 16 , atopy claim 16 , conjunctivitis claim 16 , periodontitis claim 16 , rhinitis claim 16 , tympanitis claim 16 , laryngopharyngitis claim 16 , tonsillitis claim 16 , pneumonia claim 16 , gastric ulcer claim 16 , gastritis claim 16 , Crohn's disease claim 16 , colitis claim 16 , hemorrhoids claim 16 , gout claim 16 , ankylosing spondylitis claim 16 , ...

Automobile battery and method for manufacturing pole plates

A battery includes anode plates, formed as a mesh by forming cuts in series on a lead plate strip rolled into a uniform thickness, for storing electricity in a chemically reactive state by expansion processing, cathode plates formed as a mesh for storing electricity in a chemically reactive state, separators between the anode and cathode plates for electrical insulation, mechanical separation, and the impregnation of an AGM with electrolyte, such that the chemical reaction for storing electricity is facilitated and the pressure in the cell remains constant, upper and lower cases made of polypropylene and containing the anode plates, cathode plates, separators, and electrolyte in a plurality of mutually separate cells, and a cap coupled into the screw holes formed in the cell units in the upper case, for discharging gas generated during charge and discharge when the pressure of the gas is over a permissible level.

Composition Containing Styraxlignolide A or the Aglycone Thereof as an Active Ingredient for Preventing or Treating Asthma

The present invention relates to a pharmaceutical composition for preventing or treating asthma, the composition containing styraxlignolide A or an aglycone thereof as an active ingredient. More particularly, styraxlignolide A compound is one separated from stems and barks of , and styraxlignolide A or homoegonol, which is an aglycone of styraxlignolide A and which has improved safety, has the effect of attenuating weight loss and airway hyperresponsiveness, inhibiting the generation of reactive oxygen species in airway, inhibiting generation of IgE, TGF-β1, and IL-17 in the serum and bronchoalveolar lavage fluid, inhibiting endobronchial inflammatory cell infiltration, and inhibiting the formation of a mucous plug and subepithelial fibrosis in an asthma-induced mouse model. Therefore, styraxlignolide or homoegonol can be effectively used as the active ingredient of a pharmaceutical composition for preventing or treating bronchial asthma in which airway remodeling has progressed. 1. A method for treating asthma , the method comprising administering a pharmaceutical composition containing a pharmaceutically effective amount of styraxlignolide A compound , an aglycone thereof , or a pharmaceutically acceptable salt thereof as an active ingredient to an individual.4Styrax japonica.. The method as set forth in claim 1 , wherein the styraxlignolide A compound is separated from5. The method as set forth in claim 1 , wherein asthma is one in which airway remodeling has progressed.614-. (canceled)15. A method for treating inflammation claim 1 , the method comprising administering a pharmaceutical composition containing a pharmaceutically effective amount of styraxlignolide A compound claim 1 , an aglycone thereof claim 1 , or a pharmaceutically acceptable salt thereof as an active ingredient to an individual.18Styrax japonica.. The method as set forth in claim 15 , wherein the styraxlignolide A compound is separated from 1. Field of the InventionThe present disclosure ...

INTERGRATED APPARATUS AND METHOD FOR TESTING OF SEMICONDUCTOR COMPONENTS USING A TURRET MACHINE

The invention discloses a semiconductor components delivery system associated with a turret type testing apparatus for testing integrity and functionality of semiconductor components wherein at least two input feeders loadable with semiconductor components to be vision checked, tested and/or packed are provided. The delivery system is also provided with multiple output means such as a tube, a tape or a bin or a combination thereof for semiconductor components determined to be non defective. 1. A semiconductor components delivery system associated with a turret type testing apparatus for testing integrity and functionality of semiconductor components comprising:at least two input feeders loadable with semiconductor components to be vision checked, tested and/or packed; a receiving module to receive semiconductor components fed sequentially from the input feeder;', 'a rotary or gimbal module capable of adjusting the orientation of the semiconductor component placed on this module;', 'at least one test module to perform integrity and/or functionality test and/or parametric test on the semiconductor component placed by the pick-up head on this module;', 'at least one output module for non defective semiconductor components and', 'at least one output module for rejected components; and, 'a plurality of spaced apart, sequentially arranged module positions for each input feeder, with selected module positions provided with modules, the modules seated on a locator mounted on a base plate of the testing apparatus, the modules includea plurality of pick-up heads coupled to a periphery of a rotatable turret of the testing apparatus, with a pick-up head aligned vertically above each module position, and with each pick-up head advancing to the next module position concurrently with all other pick-up heads as the turret advances one module position at a time and with each pick-up head moveable vertically up and down to place, press on and/or pick up a semiconductor component from ...

Pharmaceutical composition for preventing and treating inflamatory disease or asthma containing an extract of decaspermum fruticosum

The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma comprising the extract of Decaspermum fruticosum as an active ingredient. The extract of Decaspermum fruticosum of the present invention inhibited the increase of eosinophils in bronchoalveolar lavage fluid of the ovalbumin-induced asthma animal model, had the activity of inhibiting the secretions of immunoglobulin and chemokine (Eotaxin) in bronchoalveolar lavage fluid and blood, and inhibited the secretions of NO and TNF-α in macrophages. Therefore, the extract of Decaspermum fruticosum of the present invention can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma, and of a health functional food for the prevention and improvement of inflammatory disease or asthma.

ELECTROMAGNETIC INTERFERENCE FILTER, AND POWER SUPPLY APPARATUS AND DISPLAY APPARATUS INCLUDING THE SAME

There are provided an electromagnetic interference filter for removing common mode electromagnetic interference, in which electromagnetic interference of a low frequency band and a high frequency band is removed in a single filter because of a wide block frequency band, a power supply apparatus including the electromagnetic interference filter, and a display apparatus including the electromagnetic interference filter. The electromagnetic interference filter includes a core part including at least two legs electromagnetically coupled and forming a closed magnetic circuit; a coil part including first and second rectangular copper wires respectively wound in a single layer around the at least two legs and removing common mode electromagnetic interference included in power transferred from a power line; and a support part having a mounting area in which the core part having the coil part wound therearound is mounted. 1. An electromagnetic interference filter comprising:a core part including at least two legs electromagnetically coupled and forming a closed magnetic circuit;a coil part including first and second rectangular copper wires respectively wound in a single layer around the at least two legs and removing common mode electromagnetic interference included in power transferred from a power line; anda support part having a mounting area in which the core part having the coil part wound therearound is mounted.2. The electromagnetic interference filter of claim 1 , wherein surfaces of the at least two legs in a surface of the core part are insulation-coated.3. The electromagnetic interference filter of claim 2 , wherein the surface of the core part is insulation-coated.4. The electromagnetic interference filter of claim 1 , wherein widths of the respective first and second rectangular copper wires are greater than thicknesses and lengths thereof.5. The electromagnetic interference filter of claim 1 , wherein one end of the first rectangular copper wire is ...

Method of making leadframe strip

A leadframe strip for use in making leaded integrated circuit packages includes a plurality of integrally connected leadframes that each have a die attach pad and first and second dam bars located adjacent to opposite first and second sides of the die attach pad, respectively. A plurality of continuous lead structures extend, uninterrupted by other structure, between opposing ones of the dam bars of horizontally adjacent leadframes. The plurality of integrally connected leadframes are arranged in a plurality of vertical columns, wherein die attach pads in one vertical column are vertically offset from die attach pads in adjacent vertical columns.

Method for diagnosis and prognosis of chronic heart failure

Present application relates to methods for determining whether a subject has heart failure or is at risk of having heart failure, specifically that of heart failure with reduced left ventricular ejection fraction (HFREF) and a heart failure with preserved left ventricular ejection fraction (HFPEF), comprising determining the level of selected miRNA(s) observed in a sample obtained from the subject and wherein an altered level of the miRNA(s) compared to control indicates that the subject has heart failure or is at risk of developing heart failure. Also encompassed are methods of determining an altered risk of death or disease progression to hospitalization and death based on alteration of selected miRNAs in a sample from the subject and kits thereof.

Source Drive Integrated Circuit And Display Apparatus Including The Same

Disclosed is a source drive integrated circuit comprising: a core unit, a channel processing unit provided in each of a channel area disposed in a first side of the control area and a channel area disposed in a second side of the control area facing the first side to convert digital data, corresponding to a digital image signal transferred from the core unit, into a data voltage corresponding to an analog image signal and to output the data voltage, a resistor string provided in at least one of a pad area disposed in a third side of the control area and a pad area disposed in a fourth side of the control area facing the third side to generate a gamma voltage for converting the digital data into the data voltage and to supply the gamma voltage to the channel processing unit, and N number of gamma pads.

LED DRIVER AND DISPLAY DEVICE FOR USING THE SAME

The object of the present invention is to provide an LED driver capable of improving the stability by supplying the uniform current and widening the application range and a display device using the same. 1. An LED driver comprising:a power supply unit for supplying a driving current to a channel including a plurality of LEDs connected to each other in series or in parallel; anda capacitor provided with a first electrode which is connected to an output terminal of the power supply unit and the channel and a second electrode which is connected to a ground.2. The LED driver according to claim 1 , wherein a second capacitor is connected to the output terminal and the second capacitor is connected the first capacitor in series between the output terminal and the ground.3. The LED driver according to claim 2 , wherein a size of capacitance of the first capacitor is equal to or smaller than that of the second capacitor.4. The LED driver according to claim 1 , wherein the power supply unit includes a switch and the switch controls an amount of the driving current by performing a switching operation corresponding to the amount of the driving current.5. The LED driver according to claim 1 , wherein the power supply unit is a Buck converter.6. The LED driver according to claim 1 , wherein the power supply unit includes:an inductor provided with one end connected to a first node and the other end connected to a second node;a switch for controlling a direction of current flowing into the inductor corresponding to turn on/off operations by connecting one end thereof to the second node and the other end to the ground;a first capacitor provided with a first electrode connected to the first node and a second electrode connected to the ground;a diode provided with an anode electrode connected to the second node and a cathode connected to a third node; anda second capacitor provided with a first electrode connected to the third node and a second electrode connected to the first node.7 ...

THE COMPOSITION COMPRISING A PURIFIED EXTRACT ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT OR THE COMPOUNDS ISOLATED THEREFROM, AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE USE THEREOF

A composition comprising a purified extract isolated from var. containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD). 1Pseudolysimachion rotundumsubintegrum Pseudolysimachion rotundumsubintegrum. A pharmaceutical composition comprising the purified extract with the secondary fractionation (ATC2) containing 30-60% (w/w) verproside , 0.5-10% (w/w) veratric acid , 2-20% (w/w) catalposide , 1-10% (w/w) picroside II , 1-10% (w/w) isovanilloyl catalpol and 2-20% (w/w) 6-O-veratroyl catalpol based on the weight of total extract (100%) of var var or verproside to treat chronic obstructive pulmonary disease (COPD).25.-. (canceled)6Pseudolysimachion rotundumsubintegrumPseudolysimachion rotundumsubintegrum.. The pharmaceutical composition according to claim 1 , said purified extract with the secondary fractionation (ATC2) is characterized by being prepared by the process of adding at least one extracting solvent selected from water claim 1 , methanol claim 1 , ethanol claim 1 , butanol or the mixtures thereof to obtain dried var at the 1st step; subjecting to at least one extraction method selected from reflux extraction with hot water claim 1 , cold water extraction claim 1 , ultra-sonication or conventional extraction repeatedly claim 1 , to afford the 1st extract at 2nd step; suspending the 1st extract in 0.5-10 fold volume (v/v) of water to afford suspended extract at 3rd step; adding 0.5-20 fold volume (v/v) of butanol claim 1 , fractionating into water layer and butanol layer and collecting the butanol layer to afford the purified ...

ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME

The present invention relates to an electrolyte for a lithium secondary battery and a lithium secondary battery including the same, wherein the electrolyte comprises an organic solvent and an electrolyte additive, represented by chemical formula 1 and mixed lithium salts in the organic solvent so that room and high temperature life-time properties of the battery can be improved. Said chemical 1 is defined in the specification. 2. The electrolyte according to claim 1 , wherein Rand Rare each independently any one selected from the group consisting of a C-Calkanediyl group and a C-Calkenediyl group claim 1 , and Rand Rare linked to each other to form a four- to ten-membered alicyclic ring.3. The electrolyte according to claim 1 , wherein the electrolyte additive is any one selected from the group consisting of ethylene sulfide claim 1 , propylene sulfide claim 1 , 2-vinylthiirane claim 1 , 2 claim 1 ,3-epithiopropyl methyl ether claim 1 , 2-(trimethylsilyl)-thiirane claim 1 , 2 claim 1 ,3-di(trimethylsilyl)-thiirane claim 1 , 1-cyano-3 claim 1 ,4-epithiobutane claim 1 , isobutylene sulfide claim 1 , cyclohexene sulfide claim 1 , and mixtures thereof.4. The electrolyte according to claim 1 , wherein an amount of the electrolyte additive is 0.1 wt % to 5 wt % based on a total weight of the electrolyte.5. The electrolyte according to claim 1 , wherein the organic solvent is any one selected from the group consisting of ethylene carbonate (EC) claim 1 , propylene carbonate (PC) claim 1 , ethyl methyl carbonate (EMC) claim 1 , dimethyl carbonate (DMC) claim 1 , diethyl carbonate (DEC) claim 1 , fluoroethylene carbonate (FEC) claim 1 , methyl propyl carbonate (MPC) claim 1 , ethyl propyl carbonate (EPC) claim 1 , methyl ethyl carbonate (MEC) claim 1 , butylene carbonate (BC) claim 1 , ethyl acetate claim 1 , methyl acetate claim 1 , propyl acetate claim 1 , ethyl propionate claim 1 , methyl propionate claim 1 , propyl propionate claim 1 , and mixtures thereof.6. The ...

COMPRESSOR AND POWER GENERATING SYSTEM AND METHOD OF USING THE SAME

The present invention relates to a compressor having a cylinder block having a center bore piercedly formed at the center thereof and cylinder bores piercedly formed around the center bore, a front housing and a rear housing mounted on both ends of the cylinder block, a driving shaft rotatably passing through the front housing and the center bore, and pistons linearly reciprocating in the cylinder bores with the power received from the driving shaft to compress a refrigerant. The compressor includes a permanent magnet disposed on either of the pistons or the cylinder block and coil parts provided to the other part, wherein power generation is conducted by means of the electromagnetic induction produced by the motions of the pistons. 1. A compressor comprising:a cylinder block including a center bore formed through a center thereof and a plurality of cylinder bores formed around the center bore;a driving shaft rotatably disposed through the center bore;a plurality of pistons, each of the pistons linearly reciprocating within one of the cylinder bores via power received from the driving shaft to compress a refrigerant;a permanent magnet; anda coil part, wherein the permanent magnet is disposed in one of one of the pistons and the cylinder block and the coil part is disposed in an other of the one of the pistons and the cylinder block, wherein power generation is caused by electromagnetic induction from relative motion between the permanent magnet and the coil part disposed in the one of the pistons and the cylinder block.2. The compressor according to claim 1 , wherein each of the pistons has a body and the permanent magnet is disposed on an inner peripheral surface of the body of the one of the pistons.3. The compressor according to claim 2 , wherein the coil part is disposed in the cylinder block and configured to surround one of the cylinder bores.4. The compressor according to claim 3 , wherein the cylinder block includes a mounting groove formed therein ...

Method and system for testing semiconductor device

A method for testing a semiconductor device includes testing the semiconductor device in a plurality of operation modes sequentially, and programming the semiconductor device to operate in at least one of the operation modes when the semiconductor device passes the testing.

AIR CONDITIONER AND METHOD OF CONTROLLING THE SAME

An air conditioner includes a housing having a suction port and a discharge port, a main fan configured to draw air into the housing through the suction port and discharge air from the housing through the discharge port, an auxiliary fan configured to draw, into the housing, air discharged by the main fan and a controller configured to control a rotational speed of the auxiliary fan to change a direction in which air is discharged from the housing. 1. An air conditioner comprising:a housing including a suction port and a discharge port;a main fan configured to draw air into the housing through the suction port and discharge air from the housing through the discharge port;an auxiliary fan configured to draw, into the housing, air discharged by the main fan; anda controller configured to control a rotational speed of the auxiliary fan to change a direction in which air is discharged from the housing.2. The air conditioner according to claim 1 , wherein the controller controls the rotational speed of the auxiliary fan in accordance with a rotational speed of the main fan.3. The air conditioner according to claim 1 , further comprising an input interface configured to receive information related to an airflow direction claim 1 ,wherein the controller controls the rotational speed of the auxiliary fan in accordance with the received information related to an airflow direction.4. The air conditioner according to claim 1 , further comprising an input interface configured to receive information related to an airflow speed claim 1 ,wherein the controller controls a rotational speed of the main fan in accordance with the received information related to the airflow speed and controls the rotational speed of the auxiliary fan in accordance with the rotational speed of the main fan.5. The air conditioner according to claim 1 , further comprising an input interface configured to receive information related to an airflow direction and information related to an airflow speed claim ...

ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME

The present invention relates to an electrolyte additive comprising a salt of an anion with K or Na, the anion being derived from a nitrogen atom-containing compound, and a lithium-containing compound for forming a coating film. In addition, the present invention provides a lithium salt, a non-aqueous organic solvent, and the electrolyte additive. The present invention relates to a lithium secondary battery which includes a cathode employing a cathode active material, an anode employing an anode active material, a separator interposed between the cathode and the anode, and the non-aqueous electrolyte. 1. An electrolyte additive comprising:{'sup': +', '+, 'a salt of an anion with K or Na, the anion being derived from a nitrogen atom-containing compound, and'}a lithium-containing compound for forming a coating film.2. The electrolyte additive of claim 1 , wherein the anion derived from a nitrogen atom-containing compound is at least one selected from the group consisting of amide-based anion claim 1 , imide-based anion claim 1 , nitrile-based anion claim 1 , nitrite anion claim 1 , and nitrate anion.3. The electrolyte additive of claim 2 , wherein the amide-based anion is at least one selected from the group consisting of dimethylformamide anion claim 2 , dimethylacetamide anion claim 2 , diethylformamide anion claim 2 , diethylacetamide anion claim 2 , methylethylformamide anion claim 2 , and methylethylacetamide anion.2. The electrolyte additive of claim 2 , wherein the nitrile-based anion is at least one selected from the group consisting of acetonitrile anion claim 2 , propionitrile anion claim 2 , butyronitrile anion claim 2 , valeronitrile anion claim 2 , caprylonitrile anion claim 2 , heptanenitrile anion claim 2 , cyclopentane carbonitrile anion claim 2 , cyclohexane carbonitrile anion claim 2 , 2-fluorobenzonitrile anion claim 2 , 4-fluorobenzonitrile anion claim 2 , difluorobenzonitrile anion claim 2 , trifluorobenzonitrile anion claim 2 , phenylacetonitrile ...

Electrolyte additive and lithium secondary battery comprising the same

The present invention relates to an electrolyte additive comprising a salt of an anion with K + or Na + , the anion being derived from a nitrogen atom-containing compound, and a lithium difluoro bis(oxalato)phosphate. In addition, the present invention provides a lithium salt, a non-aqueous organic solvent, and the electrolyte additive. The present invention relates to a lithium secondary battery which includes a cathode employing a cathode active material, an anode employing an anode active material, a separator interposed between the cathode and the anode, and the non-aqueous electrolyte.

PREFILLABLE AUTO-RETRACTABLE SAFETY SYRINGE

A retractable safety syringe includes a retractable needle hub holding a needle and having a first guiding means; and a hollow barrel having a second guiding means set correspondingly to the first guiding means; and a collapsible plunger comprising of a first plunger element having a protrusion releasably coupled with a second plunger element having a longitudinal slot with a pinched zone to curb the movement of said protrusion; and a spring disposed between the needle hub and hollow barrel and acts between the needle hub and the hollow barrel. The uncoupling of the collapsible plunger triggers the retraction mechanism to enable the needle hub to retract into the barrel by the decompression force of a spring. The reliability of retraction is further improved by a longitudinal slot and a protrusion to facilitate the retreating of the collapsible plunger in an orderly way. 1. A retractable needle assembly of a retractable syringe , comprising: a first end to receive and hold a needle extending distally,', 'a nearby first guiding means on an side wall of the needle hub, and a second end being opposite to the first end; and, 'a need hub having'} an internal surface defining a chamber allowing the needle hub releasably disposed in the chamber of the hollow barrel,', 'a distal open end allowing the first end of the needle hub to protrude distally, and having a second guiding means nearby on a sidewall of the hollow barrel, and', 'a proximal open end being opposite to the distal open end;', 'wherein the second guiding means of the hollow barrel has a first portion and a second portion; and the first guiding means of the needle hub releasably engages with the first portion of the second guiding means, so that the first and the second guiding means are capable of releasably holding the needle hub until the first guiding means disengages from the first portion of the second guiding means and moves toward the second portion of the second guiding means., 'a hollow barrel having ...

AIR CONDITIONER AND METHOD FOR CONTROLLING THE SAME

An air conditioner (AC) indoor unit includes a housing having an inlet and an outlet; a heat exchanger arranged inside the housing; a blower fan for sucking in air at the inlet to be subject to heat exchange with the heat exchanger, and discharging the heat-exchanged air out of the outlet; and an air flow control device for controlling an air flow discharged from the outlet by sucking in air around the outlet. The AC indoor unit may control the direction of a discharged air flow without a conventional blade structure, thereby increasing an amount of discharged air, reducing circulation noise, and enabling design differentiation. 1. An air conditioner comprising:a housing having an inlet and an outlet;a heat exchanger arranged inside the housing;a fan arranged to draw air into the housing through the inlet to heat exchange with the heat exchanger, and discharge the heat-exchanged air from the housing through the outlet;a drain tray arranged to collect water condensed at the heat exchanger and having an opening through which air drawn through the inlet passes; anda control case arranged outside a perimeter of the opening and having a curved part that is configured to correspond to the perimeter of the opening.2. The air conditioner of claim 1 ,wherein the perimeter of the opening has a circular shape, andwherein the curved part has an arc shape to correspond to the perimeter of the opening.3. The air conditioner of claim 2 ,wherein the opening and the curved part have a same radius of curvature.4. The air conditioner of claim 1 , further comprising:a suction guide arranged to guide the air drawn through the inlet to the fan.5. The air conditioner of claim 4 ,wherein the control case is arranged between the drain tray and the suction guide.6. The air conditioner of claim 4 ,wherein the suction guide extends from the inlet toward the opening of the drain tray.7. The air conditioner of claim 4 ,wherein the suction guide extends from the inlet and passes the opening of ...

AIR CONDITIONER AND METHOD FOR CONTROLLING THE SAME

An air conditioner (AC) indoor unit includes a housing having an inlet and an outlet; a heat exchanger arranged inside the housing; a blower fan for sucking in air at the inlet to be subject to heat exchange with the heat exchanger, and discharging the heat-exchanged air out of the outlet; and an air flow control device for controlling an air flow discharged from the outlet by sucking in air around the outlet. The AC indoor unit may control the direction of a discharged air flow without a conventional blade structure, thereby increasing an amount of discharged air, reducing circulation noise, and enabling design differentiation. 1. An air conditioner comprising:a housing having an inlet and an outlet;a heat exchanger arranged inside the housing;a fan arranged to draw air into the housing through the inlet to heat exchange with the heat exchanger and discharge the heat-exchanged air from the housing through the outlet; anda drain tray arranged to collect water condensed at the heat exchanger,wherein the drain tray comprises a discharging guide rib arranged to guide the air discharged through the outlet.2. The air conditioner of claim 1 ,wherein the discharging guide rib extends in a circumferential direction relative to a center of the air conditioner.3. The air conditioner of claim 1 ,wherein the discharging guide rib extends in a radial direction relative to a center of the air conditioner.4. The air conditioner of claim 3 ,wherein the drain tray comprises a plurality of discharging guide ribs, andthe plurality of discharging guide ribs are arranged along a circumferential direction relative to the center of the air conditioner and are arranged to be separate from one another.5. The air conditioner of claim 4 ,wherein the plurality of discharging guide ribs are arranged to be parallel to one another.6. The air conditioner of claim 4 ,wherein a gap between a pair of neighboring discharging guide ribs of the plurality of discharging guide ribs increases in a flow ...

ELECTRICAL EQUIPMENT COOLING SYSTEM FOR VEHICLE

The present disclosure relates to an electrical equipment cooling system for a vehicle. For this, an embodiment relates to an electrical equipment cooling system for a vehicle, in which a condenser and a fan unit are disposed to be tilted with respect to a direction in which a running wind is inhaled. 1. An electrical equipment cooling system for a vehicle , comprising:an electric compressor compressing and circulating a refrigerant;a condenser condensing the compressed refrigerant;an expansion valve throttling the condensed refrigerant;a chiller unit performing heat exchange between the throttled refrigerant and a cooling water; anda fan unit adjacently disposed in front of the condenser and inhaling a running wind for condensing the compressed refrigerant,wherein the condenser and the fan unit are disposed to be tilted with respect to a direction in which the running wind is inhaled.2. The system of claim 1 , wherein the condenser is provided inside a casing in which a vent grill opened with a specific size to perform air movement is formed.3. The system of claim 1 , wherein the casing is formed in a cuboidal shape in which a length corresponding to a height b extends to be shorter than a length corresponding to a width a or a length corresponding to a depth c.4. The system of claim 1 , comprising a cooling water pipe forming a loop that is branched from the chiller unit and is recycled to the chiller unit after passing through a cooling object in order to cool the cooling object composed of a plurality of electrical equipment being self-heated with a specific temperature claim 1 , and providing a passage through which the cooling water moves.5. The system of claim 4 , wherein the electrical equipment is provided in a self-driving car.6. The system of claim 1 , wherein the casing is provided with:a bottom plate located on an inner bottom surface of the casing; anda stand having one end connected to the bottom plate and the other ends extending toward the condenser ...

INTEGRATED CIRCUIT PACKAGE

An integrated circuit (IC) package including a bottom leadframe, an interposer mounted on the bottom leadframe, a flipchip die mounted on the interposer and a top leadframe electrically connected to the interposer. Also, a method of making an integrated circuit (IC) package including electrically and physically attaching a die to an interposer, attaching the interposer to a bottom leadframe, attaching a discrete circuit component to the interposer and attaching a top leadframe to the bottom leadframe. 1. An integrated circuit (IC) package comprising:a bottom leadframe;an interposer mounted on said bottom leadframe;a flipchip die mounted on said interposer; anda top leadframe electrically connected to said interposer.2. The IC package of further comprising at least one field-effect transistor (FET) mounted on said interposer.3. The IC package of wherein said top leadframe is electrically connected to said bottom leadframe and said at least one FET.4. The IC package of comprising at least one passive circuit device mounted on said top leadframe.5. The IC package of wherein said passive circuit device is electrically connected to said top leadframe.6. The IC package of comprising a molding layer covering said at least one passive circuit device and portions of said top and bottom leadframes.7. The IC package of claim 1 , said bottom leadframe comprising a central pad portion.8. The IC package of claim 7 , said interposer being mounted on said bottom leadframe central pad portion and having an interposer leadframe.9. The IC package of claim 7 , said top leadframe comprising a plurality of leads claim 7 , at least one of said plurality of leads being connected to said interposer leadframe.10. The IC package of said flipchip die comprising a plurality of metal bumps claim 9 , said metal bumps being connected to said interposer leadframe.11. The IC package of claim 10 , said at least one FET being connected to said interposer leadframe.12. The IC package of at least one of ...

APPARATUS FOR PICKING, PLACING AND PRESSING SEMICONDUCTOR COMPONENTS

An apparatus for picking and placing or for picking and transferring or for picking, placing and pressing semiconductor components () is disclosed. The apparatus () comprises a motor for generating power to rotate a turret () which holds a plurality of pick up heads (), a plurality of pressers (), wherein each of said pressers () is a voice coil assembly () which consist of voice coil actuator assemblies (), at least one stationary frame () to secure said voice coil assemblies () and a controller means to control the direction and magnitude of displacement of said voice coil actuator assemblies (). When current flows into voice coil in said voice coil actuator assembly (), electromagnetic force is generated in vertical direction, forcing said actuators to press said pick up heads () located directly below said actuators at a particular moment, which in turn reaches to and press on wafers or semiconductor components located below said pick up heads. The pressing force, speed and direction of each actuator can be controlled individually. Furthermore, this invention includes safety measures wherein a real time actuator position feedback system is used to confirm the displacement of said actuators and an urging device () is used to return the actuators back to their original position in the event of power outage. 110. An apparatus for picking and placing or for picking and transferring or for picking , placing and pressing semiconductor components () comprising:{'b': '5', 'a motor in a housing () and a rotor shaft extending there out, said rotor shaft oriented vertically downward;'}{'b': 6', '7', '6, 'a turret () with a plurality of spaced apart pick up heads () mounted thereon, said turret () mounted on said rotor shaft with its vertical axis coaxial with vertical axis of said rotor shaft and rotatable horizontally about the axis of said rotor shaft;'}{'b': 1', '6, 'a first stationary horizontal frame () located vertically above said turret ();'}{'b': 8', '1, 'a ...

PHARMACEUTICAL COMPOSITION CONTAINING WOGONIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA

The present invention relates to a pharmaceutical composition for the prevention or treatment of asthma comprising Wogonin as an active ingredient. The Wogonin of the present invention is excellent not only in relieving airway hypersensitivity that causes asthma in vivo, in inhibiting reactive oxygen species generation in the airway, and in inhibiting the infiltration of inflammatory cells in the bronchus, but also in inhibiting the generation of IgE in serum and bronchoalveolar lavage fluid, and in inhibiting the expressions of Th2 cytokines in the lung. Therefore, the Wogonin of the present invention can be effectively used as a composition for the prevention, treatment, or improvement of asthma. 110-. (canceled)12. The method of claim 11 , wherein the asthma is selected from the group consisting of bronchial asthma claim 11 , allergic asthma claim 11 , atopic asthma claim 11 , non-atopic asthma claim 11 , excise-induced asthma claim 11 , aspirin-induced asthma claim 11 , cardiac asthma claim 11 , and alveolar asthma.13. The method of claim 11 , wherein treating comprises one or more of alleviating airway hypersensitivity claim 11 , inhibiting reactive oxygen generation in the airway claim 11 , and suppressing inflammatory cell infiltration in the bronchus.14. The method of claim 11 , wherein treating comprises one or more of reducing the number of inflammatory cells in the bronchus claim 11 , reducing the concentration of IgE antibody in serum claim 11 , and suppressing the expressions of Th2 cytokines. 1. Field of the InventionThe present invention relates to a pharmaceutical composition for the prevention or treatment of asthma comprising Wogonin as an active ingredient.2. Description of the Related ArtAsthma is the bronchial hypersensitivity caused by various stimulants coming in with breathing. Once stimulated, airway mucosa including bronchial mucosa swells up by inflammation, which makes the airway narrow so that cough with wheezing (breathing with high- ...

Decorative film and electronic device including the same

A decorative film and an electronic device including the same are provided. A decorative film includes: a base layer; an adhesive layer on a surface of the base layer; a pattern layer on an opposite surface of the base layer; a coating layer on the pattern layer; and a printing layer on the coating layer, and a camera hole penetrates the printing layer, the coating layer, the pattern layer, the base layer, and the adhesive layer continuously.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ASTHMA COMPRISING PISTACIA WEINMANNIFOLIA J. POISS. EX FRANCH EXTRACT OR FRACTION THEREOF

The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention effectively inhibits the secretion of immunoglobulins in serum, secretion of mucus in the bronchial tubes, and infiltration of inflammatory cells into lung tissue and thus can be usefully used as a safe preparation for preventing and treating asthma. 19-. (canceled)10. A method of treating asthma , the method comprising administering a pharmaceutical composition comprising a Pistacia weinmannifolia (Pistacia weinmannifolia J. Poiss. , Ex Franch) extract or a fraction thereof as an active ingredient to a subject suspected of having asthma.11. The method of claim 10 , wherein the extract is obtained by extraction using water claim 10 , C1-C4 alcohol claim 10 , or a mixture thereof.12. The method of claim 10 , wherein the extract is obtained by extraction using ethanol.13. The method of claim 10 , wherein the fraction is obtained by fractionation using water claim 10 , C1-C4 alcohol claim 10 , chloroform claim 10 , ethyl acetate claim 10 , hexane claim 10 , butanol claim 10 , or a mixture thereof.14. The method of claim 10 , wherein the extract or fraction thereof exhibits the following activity:(a) activity of inhibiting NO (nitric oxide) production in ...

THERMAL MANAGEMENT SYSTEM FOR VEHICLE

The present invention relates to a vehicle thermal management system which is separately provided with the final heat dissipation unit of a cooling system for cooling electronic components required for the autonomous driving of a vehicle, optimizes the modularization of units, and thereby promotes the reduction of a package. 1. A thermal management system for a vehicle as a cooling system for cooling electronic components necessary for autonomous travelling of the vehicle , the thermal management system comprising:a first compressor for inhaling and compressing refrigerant and discharging out the compressed refrigerant in a gaseous state of high temperature and high pressure, a condenser for condensing the refrigerant, a first expansion valve for expanding the refrigerant, and a chiller for absorbing heat by exchanging heat between the refrigerant and coolant, which are disposed in a first refrigerant line in order,wherein the condenser is a water cooled condenser for radiating heat by exchanging heat between the refrigerant and the coolant,further comprising:a first coolant line passing through the chiller while exchanging heat with the electronic components; and a second coolant line, to which a low-temperature radiator for exchanging heat between the coolant and air is connected, and which passes through the water cooled condenser,wherein the coolant exchanges heat with the chiller of the first refrigerant line or exchanges heat with the air using the low-temperature radiator by being connected with the second coolant line.2. The thermal management system according to claim 1 , wherein the low-temperature radiator is disposed in an air-conditioning module which performs air-conditioning in the interior of the vehicle.3. The thermal management system according to claim 1 , wherein the low-temperature radiator is disposed separately from an air-conditioning module claim 1 , which performs air-conditioning in the interior of the vehicle claim 1 , and a cooling ...

AIR CONDITIONER

An air conditioner according to an aspect of the present invention includes a housing arranged to be mounted on or embedded in a ceiling, a cover panel coupled to a lower portion of the housing, the cover panel including an inlet and an outlet, a blower fan configured to draw in air into the housing through the inlet and discharge air out of the housing through the outlet and a blade configured to open and close the outlet, the blade including a plurality of through holes to control the air discharged out of the housing through the outlet while the blade closes the outlet. With this structure, the air conditioner can discharge air in various ways by varying the wind direction, the wind speed, and the air amount of the discharged air. 1. An air conditioner comprising:a housing to be mounted on or embedded in a ceiling;a cover panel coupled to a lower portion of the housing, the cover panel including an inlet and an outlet;a blower fan configured to draw in air into the housing through the inlet and discharge air out of the housing through the outlet; anda blade configured to open and close the outlet, the blade including a plurality of through holes to control the air discharged out of the housing through the outlet while the blade closes the outlet.2. The air conditioner of claim 1 , wherein the cover panel comprises a guide forming the outlet claim 1 , the guide extending from an upstream end of the outlet to a downstream end of the outlet claim 1 ,wherein the guide comprises a first guide plane arranged to guide air in a first direction and a second guide plane arranged to change the first direction of the air guided by the first guide plane into a second direction, andwherein the second direction is nearer to the ceiling than the first direction.3. The air conditioner of claim 2 , wherein the first guide plane is formed as a curved plane and the second guide plane is formed as a flat plane.4. The air conditioner of claim 3 , wherein the first guide plane is ...

Making a flat no-lead package with exposed electroplated side lead surfaces

A method of making Flat No-Lead Packages with plated lead surfaces exposed on lateral faces thereof. The method includes providing a plurality of Flat No-Lead Packages having severed, unplated lead surfaces exposed on lateral faces thereof and having plated lead surfaces exposed on bottom faces thereof. The method further includes batch electroplating the severed unplated lead surfaces of the plurality of Flat No-Lead Packages.

Packaged semiconductor device having leadframe features preventing delamination

A semiconductor device has a leadframe with a first ( 401 a ) and a parallel second surface, and an assembly pad ( 410 ) bordered by two opposing sides, which include a plurality of through-holes ( 420 ) from the first to the second pad surface. Another pad side includes one or more elongated windows ( 421 ) between the pad surfaces. The second pad surface includes a plurality of grooves. The leadframe further has a plurality of leads ( 430 ) with opposite elongated sides castellated by indents ( 431 ). Layers ( 440 ) of bondable metals are restricted to localized areas surrounding bond spots. A semiconductor chip ( 450 ) is attached to the pad and wire-bonded ( 460 ) to the bond spots. A package ( 470 ) encapsulates the chip, wires, pad, and lead portions, and secures the leadframe into the package by filling the through-holes, windows, grooves, and indents.

STACKED SEMICONDUCTOR SYSTEM HAVING INTERPOSER OF HALF-ETCHED AND MOLDED SHEET METAL

A semiconductor system () has a flat interposer () with a first surface () in a first plane, a second surface () in a parallel second plane, and a uniform first height () between the surfaces; the interposer is patterned in metallic zones separated by gaps (), the zones include metal of the first height and metal of a second height () smaller than the first height; an insulating material fills the gaps and the zone differences between the first and the second heights. Semiconductor chips of a first () and a second () set have first terminals attached to metallic zones of the first interposer surface while the chips of the second set have their second terminals facing away from the interposer. A first leadframe () is attached to the second terminals of the second set chips, and a second leadframe () is attached to respective metallic zones of the second interposer surface. 1. An interposer for semiconductor devices comprising;a flat sheet having a first surface in a first plane, a second surface in a parallel second plane, and a uniform first height between the surfaces;the sheet patterned in metallic zones separated by gaps, the zones including metal of the first height and metal of a second height smaller than the first height; andan insulating material filling the gaps and zone differences between the first and the second heights.2. The interposer of wherein the metal of the zones is selected from a group including copper claim 1 , aluminum claim 1 , iron-nickel alloys claim 1 , and Kovar™.3. The interposer of wherein the insulating material is a molding compound.4. The interposer of wherein the first height is between about 100 and 300 μm.5. A method for fabricating an interposer for semiconductor devices claim 1 , comprising the steps of:providing a flat sheet of metal having a first height, a first surface in a first plane, and a second surface in a second plane;patterning the sheet into a plurality of metal zones separated by gaps;starting from the second ...

ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY COMPRISING SAME

The present invention may provide an electrolyte additive comprising a lithium compound for film formation and a salt of an anion, derived from a nitrogen-atom-containing compound, with Cs+ or Rb+. 1. An electrolyte additive comprising:{'sup': +', '+, 'a salt of an anion with Cs or Rb, the anion being derived from a nitrogen atom-containing compound, and'}a lithium compound for forming a coating film.2. The electrolyte additive of claim 1 , wherein the anion derived from a nitrogen atom-containing compound is one or more selected from the group consisting of amide-based anions claim 1 , imide-based anions claim 1 , nitrile-based anions claim 1 , nitrite anions claim 1 , and nitrate anions.3. The electrolyte additive of claim 2 , wherein the amide-based anion is one or more selected from the group consisting of dimethylformamide anion claim 2 , dimethylacetamide anion claim 2 , diethylformamide anion claim 2 , diethylacetamide anion claim 2 , methylethylformamide anion claim 2 , and methylethylacetamide anion.5. The electrolyte additive of claim 2 , wherein the nitrile-based anion is one or more selected from the group consisting of acetonitrile anion claim 2 , propionitrile anion claim 2 , butyronitrile anion claim 2 , valeronitrile anion claim 2 , caprylonitrile anion claim 2 , heptanenitrile anion claim 2 , cyclopentane carbonitrile anion claim 2 , cyclohexane carbonitrile anion claim 2 , 2-fluorobenzonitrile anion claim 2 , 4-fluorobenzonitrile anion claim 2 , difluorobenzonitrile anion claim 2 , trifluorobenzonitrile anion claim 2 , phenylacetonitrile anion claim 2 , 2-fluorophenylacetonitrile anion claim 2 , and 4-fluorophenylacetonitrile anion.7. The electrolyte additive of claim 1 , wherein the electrolyte additive comprises one or more selected from the group consisting of cesium bis(trifluoromethanesulfonyl)imide claim 1 , cesium nitrate claim 1 , rubidium bis(trifluoromethanesulfonyl)imide claim 1 , rubidium nitrate claim 1 , and cesium bis(fluorosulfonyl) ...

Integrated circuit package with lead lock

In a described example, a packaged integrated circuit (IC) includes a lead frame with a lead and with an IC chip mount pad. A portion of the lead adjacent to the IC chip mount pad is mechanically deformed to form a lead lock. An integrated circuit chip is mounted on a first side of the IC chip mount pad; and the integrated circuit chip, the IC chip mount pad, and the portion are covered in molding compound.

ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY COMPRISING SAME

The present invention provides an electrolyte additive comprising a salt of an anion, derived from a nitrogen-atom-containing compound, with Cs+ or Rb+. 1. An electrolyte additive comprising:{'sup': +', '+, 'a salt of an anion with Cs or Rb, and the anion being derived from a nitrogen atom-containing compound.'}2. The electrolyte additive of claim 1 , wherein the anion derived from a nitrogen atom-containing compound is one or more selected from the group consisting of amide-based anions claim 1 , imide-based anions claim 1 , nitrile-based anions claim 1 , nitrite anions claim 1 , and nitrate anions.3. The electrolyte additive of claim 2 , wherein the amide-based anion is one or more selected from the group consisting of dimethylformamide anion claim 2 , dimethylacetamide anion claim 2 , diethylformamide anion claim 2 , diethylacetamide anion claim 2 , methylethylformamide anion claim 2 , and methylethylacetamide anion.5. The electrolyte additive of claim 2 , wherein the nitrile-based anion is one or more selected from the group consisting of acetonitrile anion claim 2 , propionitrile anion claim 2 , butyronitrile anion claim 2 , valeronitrile anion claim 2 , caprylonitrile anion claim 2 , heptanenitrile anion claim 2 , cyclopentane carbonitrile anion claim 2 , cyclohexane carbonitrile anion claim 2 , 2-fluorobenzonitrile anion claim 2 , 4-fluorobenzonitrile anion claim 2 , difluorobenzonitrile anion claim 2 , trifluorobenzonitrile anion claim 2 , phenylacetonitrile anion claim 2 , 2-fluorophenylacetonitrile anion claim 2 , and 4-fluorophenylacetonitrile anion.7. The electrolyte additive of claim 1 , wherein the electrolyte additive comprises one or more selected from the group consisting of cesium bis(trifluoromethanesulfonyl)imide claim 1 , cesium nitrate claim 1 , rubidium bis(trifluoromethanesulfonyl)imide claim 1 , rubidium nitrate claim 1 , and cesium bis(fluorosulfonyl)imide.8. The electrolyte additive of claim 1 , further comprising lithium difluoro bis ...

COMPOSITION CONTAINING LIGNAN COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER

The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating cancer including a lignan compound having a specific chemical structure (Chemical Formula 1); a health functional food composition for preventing or ameliorating cancer including the lignan compound; and a method for preventing, ameliorating, or treating cancer using the composition. 2. The method of claim 1 , wherein the composition further comprises one or more compounds selected from the group consisting of dimethylpinoresinol claim 1 , dimethylliroresinol claim 1 , epieudesmin claim 1 , epimagnolin claim 1 , demethoxyaschantin claim 1 , aschantin claim 1 , and fargesin.3. The method of claim 1 , wherein the concentration of the compound of Chemical Formula 1 is in the range from 1 μM to 100 μM based on the volume of the composition.4. The method of claim 1 , wherein the composition prevents or treats cancer by inhibiting the proliferation of tumor cells via the control of the activity of extracellular signal-regulated kinase (ERK).5. (canceled)7. (canceled)8Magnoliae Flos. A method for preventing or treating cancer claim 1 , comprising administering a pharmaceutical composition; comprising the chloroform fraction of containing magnolin as an active ingredient.9. The method of claim 8 , wherein the composition further comprises one or more compounds selected from the group consisting of dimethylpinoresinol claim 8 , dimethylliroresinol claim 8 , epieudesmin claim 8 , epimagnolin claim 8 , demethoxyaschantin claim 8 , aschantin claim 8 , and fargesin.10Magnoliae Flos. The method of claim 8 , wherein the concentration of chloroform fraction is in the range from 2 μg/mL to 250 μg/mL based on the volume of the composition.11. (canceled)12Magnoliae Flos. A method for preventing or ameliorating cancer claim 8 , comprising administering a health ...

AIR CONDITIONER

Disclosed is an air conditioner to prevent deterioration of cooling or heating performance caused by re-introduction of cooling or heating air into a heat exchanger. The air conditioner includes a housing including an air discharge plate having a plurality of holes and an outlet, a heat exchanger located inside the housing, a blower fan configured to blow air heat-exchanged with the heat exchanger toward the air discharge plate or the outlet, a blade rotating between a guide position to guide a direction of air blown from the blower fan and discharged through the outlet and a closing position to close the outlet, wherein the blade includes a first blade and a second blade spaced apart from the first blade and configured to guide air blown from the blower fan toward the air discharge plate when the first blade is located at the closing position. 1. An air conditioner comprising:a housing comprising an air discharge plate that comprises a plurality of holes and an outlet;a heat exchanger located inside the housing;a blower fan configured to blow air heat-exchanged with the heat exchanger toward the air discharge plate or the outlet;a blade configured to rotate between (i) a guide position to guide a direction of air blown from the blower fan and discharged through the outlet and (ii) a closing position to close the outlet,wherein the blade comprises:a first blade comprising a plurality of blade holes and a size corresponding to that of the outlet, anda second blade spaced apart from the first blade and configured to guide air blown from the blower fan toward the air discharge plate when the first blade is located at the closing position.2. The air conditioner of claim 1 , wherein the second blade is integrated with the first blade and is configured to move together with the first blade to the guide position or the closing position.3. The air conditioner of claim 1 , further comprising a connecting blade configured to connect the first blade with the second blade.4. ...

Air conditioner and method of controlling the same

An air conditioner includes a housing having a suction port and a discharge port, a main fan configured to draw air into the housing through the suction port and discharge air from the housing through the discharge port, an auxiliary fan configured to draw, into the housing, air discharged by the main fan and a controller configured to control a rotational speed of the auxiliary fan to change a direction in which air is discharged from the housing.

Multilevel Leadframe

A method for forming a multilevel leadframe for an integrated circuit is provided. A conductive sheet is etched from one side to form a thinner region within a frame region for leads lines and bond pads. The conductive sheet is etched to form a plurality of bond pads in a first level of the thinner region arranged in at least a first row and a second row. Each bond pad has a pad width and is separated from an adjacent bond pad by a bond pad clearance distance. The conductive sheet is etched from an opposite side to form a plurality of lead lines in a second level of the thinner region having a line width and is separated from an adjacent lead line by at least a lead line clearance distance. Each bond pad of the second plurality of bond pads is connected to one of the plurality of lead lines on the second level that is routed between adjacent bond pads in the first row, so that the lead lines are routed on a different level from the bond pads.

DEVICE AND METHOD FOR CONVEYING AND FLIPPING A COMPONENT

The present invention relates to a device () and method for conveying and flipping a component () for use in conjunction with a rotary turret module (). The device () includes at least a pair of spaced apart flipping arms, a first and second flipping arms ( and ) mounted on a platform (). Each of the flipping arms () is provided with one nozzle () having one end () configured to pick the component () and another end () fixedly mounted on a shaft () supported on the flipping arm () and is operatively connected to a rotary actuating means (). The rotary actuating means () is adapted to be capable of affecting a rotational motion of the shaft (), thereby rotating the nozzles () in a counter direction by substantially degrees. The device is also provided with a linear actuating means () suitably mounted on the platform (). The linear actuating means () is operatively connected to at least one of to the flipping arms ( or and ) and is adapted to be capable of moving the flipping arm () or arms ( and ) in a horizontal direction so as to position the nozzles () substantially proximate to each other for transferring of the component () between the nozzles () and thereby, flipping the component () at 180 degrees. 1110301. A device () for conveying and flipping a component () for use in conjunction with a rotary turret module () , the device () includes{'b': 100', '300', '100', '300', '500', '100', '300', '110', '100', '310', '300', '111', '311', '10', '113', '311', '130', '330', '110', '310', '130', '330', '130', '330', '100', '300', '150', '350', '150', '350', '130', '330', '130', '330', '110', '310, 'at least a pair of spaced apart flipping arms (, ), a first flipping arm () and a second flipping arm (), mounted on a platform (); wherein each of the flipping arms (, ) is provided with one nozzle, a first nozzle () associated with the first flipping arm () and a second nozzle () associated with the second flipping arm (), each having one end (, ) configured to pick the ...

METHOD AND APPARATUS FOR ENERGY ADAPTIVE RESOURCE ALLOCATION IN ENERGY HARVESTING NETWORK

A method and apparatus for energy adaptive resource allocation in energy harvesting network are provided. The method includes: allocating, by an energy adaptive resource allocation apparatus, non-competition slots of a next frame to at least one first wireless communication device whose energy queue state exceeds a predetermined threshold value among wireless communication devices succeeded in data transmission; and allocating, by the energy adaptive resource allocation apparatus, competition slots of the same number as that of at least one third wireless communication device expected to attempt data transmission to the next frame in consideration of a harvested energy amount and an average energy harvesting rate of at least one second wireless communication device. 1. A method for energy adaptive resource allocation in energy harvesting network , the method comprising:allocating, by an energy adaptive resource allocation apparatus, non-competition slots of a next frame to at least one first wireless communication device whose energy queue state exceeds a predetermined threshold value among wireless communication devices succeeded in data transmission; andallocating, by the energy adaptive resource allocation apparatus, competition slots of the same number as that of at least one third wireless communication device expected to attempt data transmission to the next frame in consideration of a harvested energy amount and an average energy harvesting rate of at least one second wireless communication device.2. The method of claim 1 , wherein the at least one second wireless communication device is a wireless communication device that does not receive allocation of the non-competition slots among wireless communication devices connected to the energy adaptive resource allocation apparatus.3. The method of claim 1 , further comprising determining claim 1 , by the energy adaptive resource allocation apparatus claim 1 , slots succeeded in data transmission at a current ...

Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside

A composition comprising a purified extract isolated from var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD).

PHORBOL TYPE DITERPENE COMPOUND, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF VIRAL INFECTIOUS DISEASES INCLUDING SAME

The present invention relates to a diterpene compound derived from , and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose. 29-. (canceled)11. The method according to claim 10 , wherein the compound represented by Chemical Formulae 2 to 4 has activity for inducing enhanced interferon-gamma production in cells.12. The method according to claim 10 , wherein the viral infectious disease is a disease caused by one or more viruses selected from the group consisting of influenza virus claim 10 , Influenza A virus subtype H1N1 claim 10 , avian influenza virus claim 10 , rhinovirus claim 10 , adenovirus claim 10 , coronavirus claim 10 , parainfluenza virus claim 10 , respiratory syncytial virus claim 10 , Herpesvirus (HSV) claim 10 , human immunodeficiency virus (HIV) claim 10 , rotavirus and hepatitis virus.14. The method according to claim 13 , wherein the compound represented by Chemical Formulae 2 to 4 has activity for inducing enhanced interferon-gamma production in cells.15. The method according to claim 13 , wherein the viral infectious disease is a disease caused by one or more viruses selected from the group consisting of influenza virus claim 13 , Influenza A virus subtype H1N1 claim 13 , avian influenza virus claim 13 , rhinovirus claim 13 , adenovirus claim 13 , coronavirus claim 13 , parainfluenza virus claim 13 , respiratory syncytial virus claim 13 , Herpesvirus (HSV) claim 13 , human immunodeficiency virus (HIV) claim 13 , rotavirus and hepatitis virus.17. The method according to ...

AIR CONDITIONER

Disclosed herein is an air conditioner. The air conditioner includes a housing having an inlet and an outlet, a blade having a plurality of discharge holes and provided to discharge air through the plurality of discharge holes, a first opening formed between one side of the blade near the inlet and the housing when the blade discharges air through the plurality of discharge holes, and a second opening formed between the housing and the other side opposite to the one side of the blade when the blade discharges air through the plurality of discharge holes. 1An air conditioner comprising:a housing having an inlet and an outlet;a blade having a plurality of discharge holes and provided to discharge air through the plurality of discharge holes;a first opening formed between one side of the blade near the inlet and the housing when the blade discharges air through the plurality of discharge holes; anda second opening formed between the housing and the other side opposite to the one side of the blade when the blade discharges air through the plurality of discharge holes.2The air conditioner according to claim 1 , wherein the housing comprises a first guide portion to guide air discharged through the first opening in a direction away from the inlet.3The air conditioner according to claim 2 , wherein the first guide portion extends inside the outlet such that at least a portion of the first guide portion is disposed below the blade when the blade discharges air through the plurality of discharge holes.4The air conditioner according to claim 2 , wherein when the blade discharges air through the plurality of discharge holes claim 2 , and when a length along the horizontal direction of the blade is L and a length in which the first guide portion and the blade overlap in the horizontal direction is O claim 2 , the length in which the first guide portion and the blade overlap in the horizontal direction and the length along the horizontal direction of the blade satisfy the ...

Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient

The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases or asthma comprising a Lagerstroemia ovalifolia extract or a fraction thereof as an active ingredient, and a health functional food and a feed additive for preventing or improving inflammatory diseases or asthma comprising the extract or the fraction as an active ingredient.

AIR CONDITIONER AND METHOD FOR CONTROLLING THE SAME

An air conditioner (AC) indoor unit includes a housing having an inlet and an outlet; a heat exchanger arranged inside the housing; a blower fan for sucking in air at the inlet to be subject to heat exchange with the heat exchanger, and discharging the heat-exchanged air out of the outlet; and an air flow control device for controlling an air flow discharged from the outlet by sucking in air around the outlet. The AC indoor unit may control the direction of a discharged air flow without a conventional blade structure, thereby increasing an amount of discharged air, reducing circulation noise, and enabling design differentiation. 1. An air conditioner comprising:a housing having an inlet and an outlet;a main path formed in the housing to connect the inlet and the outlet;a main fan arranged in the main path to draw air into the housing through the inlet and to discharge air from the housing through the outlet; andan auxiliary fan arranged to draw air from the main path and to discharge the air, drawn from the main path, from the air conditioner to change a direction of the air discharged from the housing through the outlet by the main fan.2. The air conditioner according to claim 1 , further comprising:a guide path branched from the main path to guide the air drawn by the auxiliary fan.3. The air conditioner according to claim 1 , wherein the air discharged from the air conditioner by the auxiliary fan directly interacts with the air discharged from the housing through the outlet by the main fan to change the direction of the air discharged from the housing through the outlet by the main fan.4. The air conditioner according to claim 1 , further comprising:a heat exchanger arranged in the main path.5. The air conditioner according to claim 4 , wherein the auxiliary fan draws air from the main path between the inlet and the heat exchanger.6. The air conditioner according to claim 4 , wherein the auxiliary fan draws air from the main path between the heat exchanger and ...

INGENANE-TYPE DITERPENE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL INFECTIOUS DISEASES CONTAINING SAME

The present invention relates to an injenane-type diterpene compound derived from Liou, and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the injenane-type diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose. 29-. (canceled)11. The method according to claim 10 , wherein the compound represented by Chemical Formula 2 has activity for inducing enhanced interferon-gamma production in cells.12. The method according to claim 10 , wherein the viral infectious disease is a diseases infected by one or more viruses selected from the group consisting of influenza virus claim 10 , Influenza A virus subtype H1N1 claim 10 , avian influenza virus claim 10 , rhinovirus claim 10 , adenovirus claim 10 , coronavirus claim 10 , parainfluenza virus claim 10 , respiratory syncytial virus claim 10 , Herpesvirus (HSV) claim 10 , human immunodeficiency virus (HIV) claim 10 , rotavirus and hepatitis virus.14. The method according to claim 13 , wherein the compound represented by Chemical Formula 2 has activity for inducing enhanced interferon-gamma production in cells.15. The method according to claim 13 , wherein the viral infectious disease is a diseases infected by one or more viruses selected from the group consisting of influenza virus claim 13 , Influenza A virus subtype H1N1 claim 13 , avian influenza virus claim 13 , rhinovirus claim 13 , adenovirus claim 13 , coronavirus claim 13 , parainfluenza virus claim 13 , respiratory syncytial virus claim 13 , Herpesvirus (HSV) claim 13 , human immunodeficiency virus (HIV) claim 13 , rotavirus and hepatitis virus.17. ...

Flippable leadframe for packaged electronic system having vertically stacked chips and components

A leadframe ( 100 ) for electronic systems comprising a first sub-leadframe ( 110 ) connected by links ( 150 ) to a second sub-leadframe ( 120 ), the first and second sub-leadframe connected by tiebars ( 111, 121 ) to a frame ( 130 ); and each link having a neck ( 151 ) suitable for bending the link, the necks arrayed in a line ( 170 ) operable as the axis for bending the second sub-leadframe towards the first sub-leadframe with the necks operable as rotation pivots.

AIR CONDITIONER AND METHOD FOR CONTROLLING THE SAME

An air conditioner (AC) indoor unit includes a housing having an inlet and an outlet; a heat exchanger arranged inside the housing; a blower fan for sucking in air at the inlet to be subject to heat exchange with the heat exchanger, and discharging the heat-exchanged air out of the outlet; and an air flow control device for controlling an air flow discharged from the outlet by sucking in air around the outlet. The AC indoor unit may control the direction of a discharged air flow without a conventional blade structure, thereby increasing an amount of discharged air, reducing circulation noise, and enabling design differentiation. 1. An air conditioner comprising:a housing having an inlet and an outlet;a main fan arranged to draw air into the housing through the inlet and discharge air from the housing through the outlet;an auxiliary fan arranged to draw air around the outlet into the housing to change a direction of air being discharged from the housing through the outlet; anda guide path arranged to guide air drawn into the housing by the auxiliary fan.2. The air conditioner of claim 1 , wherein the housing includes a bottom housing having the inlet and the outlet and a middle housing provided adjacent to the bottom housing claim 1 , wherein the guide path is formed between the middle housing and the bottom housing.3. The air conditioner of claim 1 ,wherein the housing includes an inflow hole through which to draw air around the outlet into the guide path and a discharging hole through which to discharge the air from the guide path.4. The air conditioner of claim 3 ,wherein the inflow hole is located further away from a center of the air conditioner than the outlet, and the discharging hole is located closer to the center of the air conditioner than the outlet.5. The air conditioner of claim 1 ,wherein the guide path includes a first path to guide air around the outlet in a first direction in which the outlet extends and a second path to guide the air from the first ...

AIR CONDITIONER AND METHOD OF CONTROLLING THE SAME

An air conditioner includes a housing having a suction port and a discharge port, a main fan configured to draw air into the housing through the suction port and discharge air from the housing through the discharge port, an auxiliary fan configured to draw, into the housing, air discharged by the main fan and a controller configured to control a rotational speed of the auxiliary fan to change a direction in which air is discharged from the housing. 1. An air conditioner comprising:a housing including a suction port and a discharge port;a main fan configured to draw air into the housing through the suction port and discharge air from the housing through the discharge port;a first auxiliary fan configured to draw, into the housing through a first inlet provided near the discharge port, at least a portion of air discharged by the main fan;a second auxiliary fan configured to draw, into the housing through a second inlet provided near the discharge port, at least a portion of air discharged by the main fan; anda controller configured to control a rotation speed of the first auxiliary fan and a rotation speed of the second auxiliary, where a direction in which the air is discharged out of the housing by the first auxiliary fan is different from a direction in which the air is discharged out of the housing by the second auxiliary fan.2. The air conditioner according to claim 1 , wherein the first auxiliary fan changes a flow of the air discharged out of the housing toward the first inlet claim 1 , and the second auxiliary fan changes a flow of the air discharged out of the housing toward the second inlet.3. The air conditioner according to claim 1 , wherein the controller rotates the first auxiliary fan at a first rotational speed such that the air is discharged out of the housing in a first direction and rotates the second auxiliary fan at a second rotational speed such that air is discharged out of the housing in a second direction.4. The air conditioner according to ...

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CHRONIC OBSTRUCTIVE LUNG DISEASE CONTAINING, AS ACTIVE INGREDIENT, MAGNOLIAE FLOS EXTRACT, FRACTION, OR ACTIVE FRACTION THEREOF

A pharmaceutical composition includes any of an extract of , a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom as an active ingredient. The extract of , the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom inhibits the expression of MUC5AC induced by TNF-α and the promoter activity in human lung cancer mucosal cells (H292), reduces the number of inflammatory cells in the bronchoalveolar lavage fluid of the chronic obstructive pulmonary disease mouse model, inhibits the production of reactive oxygen species, and reduces the cytokines; and therefore are effective in preventing or treating chronic obstructive pulmonary disease. 1Magnoliae flos. A pharmaceutical composition comprising an extract of or a fraction or an active fraction obtained by fractionation thereof with an organic solvent as an active ingredient.2Magnoliae flos. The pharmaceutical composition according to claim 1 , wherein the extract of was extracted using an extraction solvent of water claim 1 , a Cto Clower alcohol claim 1 , or a mixture thereof.3. The pharmaceutical composition according to claim 1 , wherein the organic solvent is hexane or chloroform.4Magnoliae flos. The pharmaceutical composition according to claim 1 , wherein the fraction is a hexane fraction claim 1 , a chloroform fraction claim 1 , or a water fraction obtained by sequentially fractionating the extract of with hexane claim 1 , chloroform claim 1 , and water in this order.5. The pharmaceutical composition according to claim 1 , wherein the active fraction has been fractionated with a mixed solvent of hexane and ethyl acetate.10Magnoliae flos. A health functional food comprising an extract of or a fraction or an active fraction obtained by fractionation thereof with an organic solvent as an active ingredient.13Magnoliae flos. A method for preventing or treating chronic ...

Chemical mechanical polishing process

A chemical mechanical polishing process includes placing a substrate on a first polishing pad of a first platen, wherein the substrate has a bulk metal layer and a barrier layer; polishing the bulk metal layer by using the first polishing pad having a hardness of above 50 (Shore D) until the barrier layer is exposed; polishing the barrier layer on a second polishing pad of a second platen after removing the bulk metal layer, wherein the second polishing pad has a hardness ranging between 40 and 50 (Shore D) and includes an upper layer and a lower backing layer and the upper layer has a hardness less than 50 (Shore D).

Chemical mechanical polishing process

A copper/barrier CMP process includes (a) providing a substrate having a bulk metal layer and a barrier layer; (b) polishing the substrate with a first hard polishing pad on a first platen to substantially remove an upper portion of the bulk metal layer, wherein the first hard polishing pad has a hardness of above 50 (Shore D); (c) polishing the substrate with a second hard polishing pad on a second platen to remove residual copper, thereby exposing the barrier layer, wherein the second hard polishing pad has a hardness of above 50 (Shore D); and (d) polishing the substrate with a third hard polishing pad on a third platen to remove the barrier layer, wherein the third hard polishing pad has a hardness ranging between 40-50 (Shore D).

Chemical mechanical polishing process

A copper/barrier CMP process includes (a) providing a substrate having a bulk metal layer and a barrier layer; (b) polishing the substrate with a first hard polishing pad on a first platen to substantially remove an upper portion of the bulk metal layer, wherein the first hard polishing pad has a hardness of above 50 (Shore D); (c) polishing the substrate with a second hard polishing pad on a second platen to remove residual copper, thereby exposing the barrier layer, wherein the second hard polishing pad has a hardness of above 50 (Shore D); and (d) polishing the substrate with a third hard polishing pad on a third platen to remove the barrier layer, wherein the third hard polishing pad has a hardness ranging between 40-50 (Shore D).

ELECTROLYTE ADDITIVE, BATTERY ELECTROLYTE INCLUDING ELECTROLYTE ADDITIVE, AND SECONDARY BATTERY INCLUDING BATTERY ELECTROLYTE

The present invention relates to an electrolyte additive, a battery electrolyte including the electrolyte additive, and a secondary battery, and more particularly, to an electrolyte additive including a compound represented by Chemical Formula 1, an electrolyte including the electrolyte additive, and a secondary battery including the electrolyte. According to the present invention, due to low charging resistance, charging efficiency and output may be improved. In addition, the present invention has an effect of providing a secondary battery having a long lifespan and excellent capacity retention at high temperature. 4. The electrolyte according to claim 3 , wherein claim 3 , based on 100% by weight in total of the electrolyte claim 3 , the compound represented by Chemical Formula 1 is comprised in an amount of 0.1 to 10% by weight.5. The electrolyte according to claim 3 , wherein the compound represented by Chemical Formula 1 has a symmetric structure by satisfying “m=n”.6. The electrolyte according to claim 3 , wherein the organic solvent comprises one or more selected from the group consisting of ethylene carbonate (EC) claim 3 , diethyl carbonate (DEC) claim 3 , ethylmethyl carbonate (EMC) claim 3 , dimethyl carbonate (DMC) claim 3 , propylene carbonate (PC) claim 3 , dipropyl carbonate (DPC) claim 3 , butylene carbonate claim 3 , methylpropyl carbonate claim 3 , and ethylpropyl carbonate.7. The electrolyte according to claim 3 , wherein the lithium salt comprises one or more selected from the group consisting of LiPF claim 3 , LiFLiCl claim 3 , LiBr claim 3 , LiI claim 3 , LiClO claim 3 , LiBCl claim 3 , LiCFSO claim 3 , LiCFCO claim 3 , LiAsF claim 3 , LiSbF claim 3 , LiAlCl claim 3 , CHSOLi claim 3 , CFSOLi claim 3 , and (CFSO)NLi.8. The electrolyte according to claim 3 , wherein the electrolyte comprises a metal phosphate-based compound.9. The electrolyte according to claim 8 , wherein the metal phosphate-based compound comprises one or more selected from the ...

Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same

A novel benzoxazole derivative of formula (I) or a pharmaceutically acceptable salt thereof is effective for inhibiting 5-lipoxygenase which is useful for preventing or treating leukotriene-related diseases. The prevention also provides a pharmaceutical composition containing same and a method for preventing or treating leukotriene-related diseases.

Modulo reduction method using precalculated table in e.g. smart card

The modulo reduction method operates in several steps. The first step is to look up a value stored in a table with the aid of an index formed of a number of high order bits, and adds the value accessed in the table to a number of low order bits. If the result obtained by the addition produces an overflow, the overflow is suppressed and the operation terminated. If on the other hand overflow does not occur, N on modulo N is added to the result obtained from the addition, and the operation terminated. The value with a most significant bit of one is selected when the value of N is determined by this last operation.

The composition comprising atc2 purified extract isolated from pseudolysimachion rotundum var. subintegrum for preventing or treating a chronic obstructive pulmonary disease and the use thereof

The present invention relates to a composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for preventing or treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD).

Modulo reduction process using a pre-calculated table.

Electrically programmable and erasable semiconductor memory device

The invention relates to semiconductor technology. <??>The invention consists in a programmable read-only memory which can be erased page by page and whose memory cells consist of flash type floating-gate transistors. The memory cell array is divided into several pages (PG1, PG2N), and each page comprises a set of bit lines, a set of common source lines and a set of word lines. A set of erasure selection circuits (400) is provided in correspondence with the respective pages for the purpose of erasing the cells in a selected page. <??>Application to computing.

A method of removing hemp bast pectin using microorganism

A method for extracting hemp bast using microorganisms is provided. More particularly, a method for extracting hemp bast using microorganisms by degumming pectin in hemp bast using the microorganisms and degrading the unity of the bast to thereby obtain pure fibers is provided.

Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same

The present invention relates to a diterpene compound derived from Aleurites fordii , and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose.

The composition comprising atc2 purified extract isolated from pseudolysimachion rotundum var. subintegrum for preventing or treating a chronic obstructive pulmonary disease and the use thereof

The present invention relates to a composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for preventing or treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD).

pre-filled self-retracting safety syringe

resumo "seringa de segurança auto-retrátil pré-cheia” uma seringa de segurança retrátil (1) inclui uma parte central de agulha retrátil (4) retendo uma agulha (40) tendo um primeiro meio de orientação (42), um cilindro oco (2) que tem um segundo meio de orientação (22) correspondendo ao primeiro meio de orientação (42), um êmbolo deformável (6) que compreende um primeiro elemento de êmbolo (64) dotado de uma saliência (603) acoplado frouxamente com um segundo elemento de êmbolo (62) dotado de uma ranhura longitudinal (602) com uma zona de aperto (6021) para encurtar o movimento da dita saliência (603) e uma mola (8) disposta entre a parte central da agulha (4) e o cilindro oco (2) que atua entre a parte central da agulha (4) e o cilindro oco (2). o desacoplamento do êmbolo deformável (6) aciona o mecanismo de retração a fim de permitir que a parte central da agulha (4) se retraia para o cilindro (2) por uma ranhura longitudinal (602) e uma saliência (603) a fim de facilitar o recuo do êmbolo deformável (6) para um modo mais ordenado. abstract "pre-filled self-retracting safety syringe" a retractable safety syringe (1) includes a retractable needle center portion (4) retaining a needle (40) having a first guiding means (42), a hollow cylinder ( 2) having a second guide means (22) corresponding to the first guide means (42), a collapsible plunger (6) comprising a first plunger element (64) provided with a projection (603) loosely coupled with a second piston element (62) provided with a longitudinal groove (602) with a gripping zone (6021) to shorten the movement of said projection (603) and a spring (8) arranged between the central part of the needle (4) and the hollow cylinder (2) that acts between the central part of the needle (4) and the hollow cylinder (2). retracts into the cylinder (2) by a longitudinal groove (602) and a projection (603) in order to facilitate the recoil of the deformable piston (6) for a more orderly mode.

Metal free reactive dyes, process for the production thereof and their use

The present invention relates to reactive dyes of the formula (I) in which A, B, a and K are defined as given in claim, a process for preparing them, and their use for dyeing and printing hydroxyl-, amino-, and/or carboxamido-containing materials.

Compositions comprising an extract of tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases

The present invention relates to an anoikis-inducing agent comprising a Tiarella polyphylla extract, a tiarellic acid compound isolated therefrom or a pharmaceutically acceptable salt thereof, which is specific to cancer cells expressing a tumor-associated antigen L6 or a homolog thereof. The Tiarella polyphylla extract, the tiarellic acid compound isolated therefrom or pharmaceutically acceptable salt thereof of the present invention leads to loss of cell adhesion to reduce cancer cell proliferation and exhibits the effect of inducing cell death in cancer cells expressing a tumor-associated antigen L6 or a homolog thereof, thereby being used for preventing and treating cancer diseases due to a tumor-associated antigen L.beta. or a homolog thereof.

A composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC4 release in vitro test and the suppressive effect on the IgE level and the cytokine(IL-4, IL-5 and IL- 13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

Metal-free reactive dyes, process for the production thereof and their use

Metal-free reactive dyes, process for the production thereof and their use The present invention relates to reactive dyes of the formula (I), in which A, B, a and K are defined as given in claim, a process for preparing them, and their use for dyeing and printing hydroxyl-, amino-, and/or carboxamido-containing materials.

Prefillable auto-retractable safety syringe

A retractable safety syringe includes a retractable needle hub holding a needle and having a first guiding means; and a hollow barrel having a second guiding means set correspondingly to the first guiding means; and a collapsible plunger comprising of a first plunger element having a protrusion releasably coupled with a second plunger element having a longitudinal slot with a pinched zone to curb the movement of said protrusion; and a spring disposed between the needle hub and hollow barrel and acts between the needle hub and the hollow barrel. The uncoupling of the collapsible plunger triggers the retraction mechanism to enable the needle hub to retract into the barrel by the decompression force of a spring. The reliability of retraction is further improved by a longitudinal slot and a protrusion to facilitate the retreating of the collapsible plunger in an orderly way.

Compound isolated from pseudolysimachion rotundum var. subintegrum

The present invention relates to a novel methanocyclopenta[e][1,3]dioxepin-7-yl 3,4-dihydroxybenzoate derivative (KS534) represented below as the Chemical Formula 1, the pharmaceutically acceptable salt or solvates thereof, a composition comprising the same as an active ingredient for preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease (COPD) and the use thereof. Formula (1)

Organic light emitting device and method of manufacturing the same

An organic light emitting device including an anode (2) having a high light transmissivity and a controllable work function, and allowing for a high degree of freedom for selection of a cathode (4), and a method of manufacturing the same. The anode of the organic light emitting device includes a first layer (21). The first layer (21) includes a first metal oxide, and a second metal oxide differing from the first metal oxide and doped into the first metal oxide. The cathode faces the anode, and an organic layer (3) including an emission layer between the anode and the cathode.

Electrolyte additive and lithium secondary battery comprising same

The present invention can provide an electrolyte additive comprising a lithium compound for film formation and a salt of an anion, derived from a nitrogen-atom-containing compound, with Cs + or Rb + . The present invention also provides a non-aqueous electrolyte comprising a lithium salt, a non-aqueous organic solvent, and the electrolyte additive, wherein the electrolyte additive may further comprise lithium difluoro bis oxalato phosphate, and can provide a lithium secondary battery comprising: a positive electrode comprising a positive active material; a negative electrode comprising a negative active material; a separator interposed between the positive electrode and the negative electrode; and the nonaqueous electrolyte. A secondary battery comprising the electrolyte additive according to the present invention can have an improved high-temperature output characteristic.

Microcell system in digital cellular

A cellular telephone system is described of the type wherein a plurality of contiguous cells, each having a different assigned set of transmission frequency channels, are arranged with handoff controller (98) for maintaining continuous communication with mobile telephones moving from cell to cell. The system allows multiple access by including device (251) for assigning at least one of the frequencies in the assigned set of frequencies to more than one mobile telephone. Three embodiments of the multiple access systems are disclosed. In one embodiment, frequency division multiple access is used (Fig. 4). In a second embodiment, time division multiple access is used (Fig. 4). In a third embodiment, code division multiple access is used (Fig. 10).

Automatically retractable safety injector for non-liquid material

Electrolyte additive and lithium secondary battery comprising the same

The present invention relates to an electrolyte additive comprising a salt of an anion with K + or Na + , the anion being derived from a nitrogen atom-containing compound, and a lithium-containing compound for forming a coating film. In addition, the present invention provides a lithium salt, a non-aqueous organic solvent, and the electrolyte additive. The present invention relates to a lithium secondary battery which includes a cathode employing a cathode active material, an anode employing an anode active material, a separator interposed between the cathode and the anode, and the non-aqueous electrolyte.

Battery case cover

Provided is a battery case cover which can be produced through a single process, by integrally forming the structural components of a battery case cover such as a recovering part, a cell partition part and a gas inlet part on the bottom surface, while forming the recovering part in the shape of a pipe and applying a vent cap mode to the gas inlet part.

CMP method and device capable of avoiding slurry residues

A method for chemical mechanical polishing (CMP) includes a rinsing process performed to clean an orifice of a slurry supplier and other elements of a CMP device. The CMP device includes least one nozzle disposed in the periphery of a base. The function of the nozzle is to spray DI water to the orifice of the slurry supplier so as to prevent slurry residue and clogging.

Medical safety injector and plunger combination for medical safety injection

A medical safety injector includes: a needle hub connected with a needle; a hollow barrel for retaining the needle hub and, upon completion of an injection, guiding the needle hub to retract into the hollow barrel; and a plunger combination disposed within the hollow barrel. The plunger combination includes a retractable plunger and a hollow shank partially muff-coupled with the retractable plunger. The retractable plunger has an exterior sidewall formed with at least one protrusion in a muff-coupled region with the hollow shank, for being correspondingly snap-fitted with at least one recess formed on an interior sidewall of the hollow shank. If a user continues to apply a force to the plunger combination after the medical safety injector accomplishes an injection, the retractable plunger will retract smoothly into the hollow shank to free space in the hollow barrel for receiving the needle hub, thereby improving single-handed operability of the injector.

Beanie with earphone

Prefillable auto-retractable safety syringe

Improvements to a solar chimney power plant

The present invention relates to a solar chimney power plant (10) wherein said solar chimney power plant (10) comprises a collector (12) and a transparent cover (14) positioned in an angular position in relation to the ground. The solar chimney power plant (10) is constructed with a layer of the transparent cover (14), followed by the collector (12) and finally with an insulated layer (22). Flue gas is introduced between the insulated layer (22) and collector (12) via an inlet (18) and is exhausted via outlet (28). The said flue gas is exhausted into the chimney (24) thus creating an increase in air speed in the chimney (24) and resulting the wind rotor (26) to rotate at a higher speed and thus generating more electricity. The solar chimney power plant is operable without any interruption and is not influence by the intensity of solar radiation.

Agastache rugosa extract having anti-inflammatory activity and anti-atherogenic activity

Leadframe packages having enhanced ground-bond reliability

Various semiconductor package arrangements and methods that improve the reliability of wire bonding a die to ground or other outside contacts are described. In one aspect, selected ground pads on the die are wire bonded to a bonding region located on the tie bar portion of the lead frame. The tie bar is connected to an exposed die attach pad that is downset from the bonding region of the tie bar. In some embodiments, the bonding region and the leads are at substantially the same elevation above the die and die attach pad. The die, bonding wires, and at least a portion of the lead frame can be encapsulated with a plastic encapsulant material while leaving a contact surface of the die attach pad exposed to facilitate electrically coupling the die attach pad to an external device.

Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, antiallergic and anti-asthmatic activity. The extractof Pseudolysimachion genus plantand the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL- 13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

Automatically retractable safety blood sampler

This invention of the automatically retractable safety blood sampler comprises a needle with a needle hub, a needle tube, a rubber washer, and a protective sheath, a cap, a barrel, a spring, and a blood collection tube. With blood collected, the blood collection tube is used for coercing the needle head to move forward, driving a sliding movement between slides on the needle hub and the snap hook on the barrel via the spring's force to automatically complete retraction of the needle head.

CMP method and device capable of avoiding slurry residues

Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, antiallergic and anti-asthmatic activity. The extractof Pseudolysimachion genus plantand the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL- 13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

Toileting and toilet training devices for children

The device is a toilet receptacle,, for assisting in the toilet training of newborns, infants, toddle and preschoolers. It is configured for use with a toilet or receiving pot. The toilet receptacle includes a left hand footrest configured to be disposed at a front end or side wall of the toilet receptacle and configured for raising the left hand knee of the child towards the chest whilst sitting on the seat. The device also includes a right hand footrest configured to be disposed at front end or side wall of the toilet receptacle and configured for raising the right hand knee of the child or toddler towards the chest whilst sitting on the seat. The device is equipped with sound devices, which are configured to provide two, or more predetermined sounds, words and music to induce actuation (defecation or urination) by the user. The device is configured to be attached to any clean flat surface, to the seat of a conventional toilet, to the footrest of a squatting toilet or is built as an 'integral low sitting' toileting unit.

Electrolyte additive and lithium secondary battery comprising same

Display device

A display device is disclosed. In one embodiment, the display device includes a display panel, a housing which houses the display panel and a frame which is disposed under the housing and comprises a first bottom portion. The first bottom portion includes a first bottom surface which is an upper surface thereof and a first base surface which is a lower surface thereof, and the frame includes a groove recessed from the first bottom surface.

Automatic tilt compensator and optical recording/reproducing apparatus having the same

An automatic tilt compensator senses and automatically compensates for a disc deformation while an optical recording and/or reproducing apparatus operates. The automatic tilt compensator of an optical recording/reproducing apparatus has a disc deformation detecting section for sensing a deformation direction and a deformation degree of a disc seated and rotated on a disc rotation unit of a deck base and for outputting a predetermined signal, and a level adjustment section for elevating and lowering a pair of guide shafts movably supporting a pickup unit on the deck base while being operated by the signal from the disc deformation detecting section, to thereby adjust the level of the pickup unit corresponding to the deformation degree of the disc. According to this, the level of the pickup unit according to the deformation direction or the deformation degree of the disc can be automatically adjusted while the optical recording/reproducing device is operated. Accordingly, even when a deformed disc is inserted, since the level of the pickup unit is automatically adjusted according to the deformed disc, errors in recording and reproducing information caused due to the deformed disc can be remarkably reduced.

Biosorbent from pandanus helicopus leaves and method of producing thereof

The present invention relates to a biosorbent from Pandanus helicopus leaves for used in the removal of pollutants from aqueous solutions and a method of producing such biosorbent thereof. Accordingly, the biosorbent comprises leaves of Pandanus helicopus with different mesh sizes ranging from 0.063 mm to 2 mm. The method of producing such biosorbent comprises the steps of: (a) drying Pandanus helicopus leaves to obtain dried leaves; (b) cutting the dried leaves into 1 cm long to obtain cut dried leaves; (c) milling the cut dried leaves to obtain milled leaves; (d) sieving the milled leaves to obtain sieved leaves; (e) soaking the sieved leaves in deionized water for an hour to obtain soaked sieved leaves; (f) rinsing the soaked sieved leaves with deionized water until pH 7 to obtain rinsed sieved leaves; g) drying the rinsed sieved leaves to obtain dried sieved leaves; (h) mixing the dried sieved leaves with sago starch gelatin paste to obtain a mixture; (i) converting the mixture into a spherical- shape form to obtain biosorbent in spherical-shape form; and (j) drying the biosorbent in spherical-shape form. The method further comprising the step of (k) pelletizing the dried sieved leaves to obtain biosorbent in pellet form. (FIGURE 7)

Lignan-containing extracts of manoliae flos and use thereof in the treatment and prevention of chronic obstructive pulmonary disease (copd)

The present invention relates to an extract of Magnoliae flos, a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom, represented by Formula I

A composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC4 release in vitro test and the suppressive effect on the IgE level and the cytokine(IL-4, IL-5 and IL- 13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

Air conditioner

Prefillable auto-retractable safety syringe

A retractable safety syringe (1) includes a retractable needle hub (4) holding a needle (40) and having a first guiding means (42), a hollow barrel (2) having a second guiding means (22) set correspondingly to the first guiding means (42), a collapsible plunger (6) comprising a first plunger element (64) having a protrusion (603) releasably coupled with a second plunger element (62) having a longitudinal slot (602) with a pinched zone (6021) to curb the movement of said protrusion (603), and a spring (8) disposed between the needle hub (4) and the hollow barrel (2) and acts between the needle hub (4) and the hollow barrel (2). The uncoupling of the collapsible plunger (6) triggers the retraction mechanism to enable the needle hub (4) to retract into the barrel (2) by a longitudinal slot (602) and a protrusion (603) to facilitate the retreating of the collapsible plunger (6) in an orderly way.

Metal-free reactive dyes, process for the production thereof and their use

Metal-free reactive dyes, process for the production thereof and their use The present invention relates to reactive dyes of the formula (I), in which A, B, a and K are defined as given in claim, a process for preparing them, and their use for dyeing and printing hydroxyl-, amino-, and/or carboxamido-containing materials.

Air conditioner and method for controlling the same

An air conditioner (AC) indoor unit includes a housing having an inlet and an outlet; a heat exchanger arranged inside the housing; a blower fan for sucking in air at the inlet to be subject to heat exchange with the heat exchanger, and discharging the heat-exchanged air out of the outlet; and an air flow control device for controlling an air flow discharged from the outlet by sucking in air around the outlet. The AC indoor unit may control the direction of a discharged air flow without a conventional blade structure, thereby increasing an amount of discharged air, reducing circulation noise, and enabling design differentiation.